Personal information

Websites & social links

LinkedIn Profile

Activities

Collapse all

Employment (4)

International AIDS Vaccine Initiative: New York, New York, US

2023-01-03 to present | Principal Scientist (Design and Development Laboratory)
Employment
Source: Self-asserted source
Thomas Postler

Columbia University Irving Medical Center: New York, NY, US

2019-07-01 to 2022-12-31 | Assistant Professor of Microbiology & Immunology at the Columbia University Medical Center (Microbiology & Immunology)
Employment
Source: Self-asserted source
Thomas Postler

Columbia University Medical Center: New York, NY, US

2017-09-01 to 2019-06-30 | Associate Research Scientist (Microbiology & Immunology)
Employment
Source: Self-asserted source
Thomas Postler

Columbia University Medical Center: New York, NY, US

2012-09 to 2017-08-31 | Postdoctoral Research Scientist (Microbiology & Immunology)
Employment
Source: Self-asserted source
Thomas Postler

Education and qualifications (2)

Harvard Medical School/Friedrich Alexander University Erlangen-Nürnberg: Boston, MA, US

2006 to 2012 | Ph.D. (Dr. rer. nat.) (Microbiology)
Education
Source: Self-asserted source
Thomas Postler

Friedrich-Alexander-Universitat Erlangen-Nurnberg: Erlangen, Bayern, DE

2001 to 2006 | B.Sc./M.Sc.
Education
Source: Self-asserted source
Thomas Postler

Funding (5)

Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis

2024-08 to 2025-03 | Grant
NATL INST OF HLTH NIAID (Bethesda, US)
URL: https://reporter.nih.gov/project-details/10857345
GRANT_NUMBER: R61 AI169132
Source: Self-asserted source
Thomas Postler

Exploring the role of a novel autoimmune disease-associated lncRNA in Treg biology

2022-11 to 2024-10 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, Maryland, US)
URL: https://reporter.nih.gov/project-details/10598708
GRANT_NUMBER: R21AI168949
Source: Self-asserted source
Thomas Postler

Exploring a novel lncRNA regulator of T-cell function

2021-06 to 2023-05 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, Md., US)
GRANT_NUMBER: R21AI156616
Source: Self-asserted source
Thomas Postler
grade
Preferred source (of 2)‎

Understanding the importance of IkB-b as a selective co-activator of NF-kB signaling

2018-06-01 to 2023-05-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.7570063
GRANT_NUMBER: R01AI139217
Source: Self-asserted source
Thomas Postler via DimensionsWizard

The Role of κB-Ras Proteins in the Regulation of Immune Signaling

2014-09 to 2015-09 | Salary award
Deutsche Forschungsgemeinschaft (Bonn, DE)
URL: https://gepris.dfg.de/gepris/projekt/264167063?language=en
GRANT_NUMBER:

PO 1946/1-1
Source: Self-asserted source
Thomas Postler

Peer review (8 reviews for 5 publications/grants)

Review activity for Biomedicines. (1)
Review activity for Infectious disease reports. (1)
Review activity for Molecules. (2)
Review activity for PloS one. (1)
Review activity for PLOS pathogens : (3)
How many people are using ORCID?